We have previously demonstrated that high nuclear expression of the RNA binding motif protein 3 (RBM3) is associated with an improved outcome in several major cancer forms, i.e. breast, ovarian, colorectal and prostate cancer and malignant melanoma [10-14]. Here, RBM3 is linked to prostate cancer.